DOX
Amdocs Limited
DOX has lower modeled downside risk, despite its lower overall score.
SNDK
Sandisk Corporation
SNDK has the edge over DOX overall, supported by stronger modeled upside and stronger fundamentals.
DOX Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Healthy | |
| Healthy | |
| Healthy |
DOX's profitability, cash flow and balance sheet are currently healthy, and its revenue is stable.
SNDK Fundamentals
| Metric | Status |
|---|---|
| Strong | |
| Strong | |
| Strong | |
| Strong |
SNDK's revenue, profitability, cash flow and balance sheet are all currently strong.
DOX PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 8.1x | $44.11 | — |
| Current | 11x | $44.11 | — |
| Cheap | 14x | $60.81 | +38% |
| Fair | 18x | $76.51 | +73% |
| Expensive | 20x | $85.23 | +93% |
Historical ranges are pointers, not guarantees.
DOX has the edge over SNDK in the historical PE scenario, which offers more potential upside but is not a forecast.
SNDK PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 3.8x | $937 | — |
| Current | 7.5x | $937 | — |
| Cheap | 17x | $2,173 | +132% |
| Fair | 24x | $3,048 | +225% |
| Expensive | 59x | $7,452 | +695% |
Historical ranges are pointers, not guarantees.
SNDK's PE is 7.5x, but its earnings don't support one, so it isn't a reliable read right now.
DOX Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Strong decline | |
| Decline | |
| Weakening | |
| Limited | |
| Low |
Analysts expect DOX's earnings and revenue to decline, with profitability weakening. However, they disagree widely on these estimates.
SNDK Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Strong growth | |
| Strong growth | |
| Strongly improving | |
| Moderate | |
| High |
SNDK has the edge over DOX on the outlook, with more favorable earnings and revenue expectations.
DOX Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $5.47 | +30% |
| Q2 2026 | $4.20 | -14% |
| Q1 2026 | $5.00 | +5.9% |
| Q4 2025 | $5.17 | +21% |
| Q3 2025 | $5.05 | +20% |
| Q2 2025 | $4.90 | +13% |
| Q1 2025 | $4.72 | +6.1% |
| Q4 2024 | $4.28 | -8.4% |
| Q3 2024 | $4.21 | -6% |
DOX earned $4.20 per share over the past year, down 14% from the year before.
SNDK Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $247.30 | +97% |
| Q3 2026 | $125.61 | +$137.63 |
| Q2 2026 | $73.76 | +$85.07 |
| Q2 2025 | -$11.31 | -$6.65 |
SNDK has the edge over DOX in the latest year-over-year earnings comparison.
DOX Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q2 2026 | $1.2B | +2.7% |
| Q1 2026 | $1.2B | +3.9% |
| Q4 2025 | $1.2B | +4.1% |
| Q3 2025 | $1.2B | -9% |
| Q2 2025 | $1.1B | -8.4% |
| Q1 2025 | $1.1B | -9.4% |
| Q4 2024 | $1.1B | -11% |
| Q3 2024 | $1.3B | +1.7% |
DOX's revenue grew through 2021 and has held roughly level since: $1.2B last quarter, up 2.7% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q2 2026 | 18% | +0.3 points |
| Q1 2026 | 16% | -1.1 points |
| Q4 2025 | 18% | 0 points |
| Q3 2025 | 18% | +9 points |
| Q2 2025 | 18% | +3.6 points |
| Q1 2025 | 18% | +5 points |
| Q4 2024 | 18% | +3.1 points |
| Q3 2024 | 8.9% | -2.3 points |
DOX's operating margin was 18% last quarter, about level with the same quarter a year ago, near the top of its range since 2019.
SNDK Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $11B | +378% |
| Q2 2026 | $9B | +372% |
| Q1 2026 | $6B | +251% |
| Q4 2025 | $3B | +61% |
| Q3 2025 | $2.3B | +23% |
| Q2 2025 | $1.9B | +8% |
| Q1 2025 | $1.7B | -0.6% |
| Q4 2024 | $1.9B | +13% |
SNDK has the edge over DOX on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 80% | +72 points |
| Q2 2026 | 78% | +78 points |
| Q1 2026 | 69% | +180 points |
| Q4 2025 | 35% | +25 points |
| Q3 2025 | 7.6% | -9 points |
| Q2 2025 | 0.9% | N/A |
| Q1 2025 | -111% | -122 points |
| Q4 2024 | 10% | +6.6 points |
SNDK has the edge over DOX on profitability, with a higher operating margin.
DOX Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q2 2026 | $171.9M | -19% |
| Q1 2026 | $80.3M | -49% |
| Q4 2025 | $187.9M | +140% |
| Q3 2025 | $198.6M | +3.4% |
| Q2 2025 | $211.8M | +21% |
| Q1 2025 | $156.5M | +38% |
| Q4 2024 | $78.2M | -44% |
| Q3 2024 | $192.1M | -22% |
DOX's free cash flow has been positive every quarter for seven years: $639M over the past year, about the same as the year before.
SNDK Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $6.3B | +1340% |
| Q2 2026 | $7.1B | +14355% |
| Q1 2026 | $3B | +$3B |
| Q3 2025 | $438M | +$636M |
| Q2 2025 | $49M | +$217M |
| Q1 2025 | -$18M | +$23M |
| Q3 2024 | -$198M | -$157M |
SNDK has the edge over DOX on cash flow, with more consistent year-over-year improvement.
DOX Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -1.7% | -1.8M shares |
| 1 year | -4.9% | -5.5M shares |
| 3 years | -12% | -14.7M shares |
| 5 years | -17% | -22.4M shares |
| Available history | -22% | -30.5M shares |
DOX has the edge over SNDK on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q2 2026 | $142.6M |
| Q1 2026 | $138.3M |
| Q4 2025 | $146.2M |
| Q3 2025 | $136.4M |
| Q2 2025 | $135.2M |
| Q1 2025 | $135.2M |
| Q4 2024 | $144.5M |
| Q3 2024 | $119.8M |
DOX spent $563M buying back its own shares over the past year, up 5.4% from the year before.
SNDK Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.6% | -1M shares |
| 1 year | +3.4% | +5M shares |
| 3 years | +6.9% | +10M shares |
SNDK has 154M diluted shares, up 3.4% from a year ago.
| Quarter | Spent |
|---|---|
| Q3 2026 | $5B |
| Q3 2024 | — |
| Q2 2024 | — |
| Q1 2024 | — |
| Q4 2023 | — |
| Q3 2023 | — |
DOX Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q2 2026 | 1.0x | Healthy |
| Q1 2026 | 0.9x | Very low |
| Q4 2025 | 0.7x | Very low |
| Q3 2025 | 0.5x | Very low |
| Q2 2025 | 0.7x | Very low |
| Q1 2025 | 0.7x | Very low |
| Q4 2024 | 0.7x | Very low |
| Q3 2024 | 0.6x | Very low |
DOX's net debt is about a year of its operating earnings (EBITDA), up from less than a year a year ago.
SNDK Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -0.2x | Net Cash |
| Q2 2026 | -0.4x | Net Cash |
| Q1 2026 | -0.7x | Net Cash |
SNDK has the edge over DOX on leverage, with a lower net debt burden relative to earnings.
DOX Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 30.4 | Neutral |
| Stochastic | 36.7 | Neutral |
DOX's weekly RSI is 30 (neutral) and its Stochastic is 37 (neutral).
SNDK Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 40.2 | Neutral |
| Stochastic | 10.6 | Oversold |
SNDK's weekly RSI is 40 (neutral) and its Stochastic is 11 (oversold).
DOX PE vs Technology Sector
| Metric | DOX | Sector median | Relative |
|---|---|---|---|
| PE | 11x | 28x | 62% below |
| PE % | 2 | 35 | 33 pts below |
DOX is trading at 11x earnings, a 62% discount to the Technology sector's median of 28x.
SNDK PE vs Technology Sector
| Metric | SNDK | Sector median | Relative |
|---|---|---|---|
| PE | 7.5x | 28x | 73% below |
| PE % | 4 | 27 | 23 pts below |
SNDK has the edge over DOX on valuation relative to its sector.
DOX Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $55.8 | 21% below |
| 20 week MA | $56.7 | 22% below |
| 50 week MA | $64.2 | 31% below |
| 100 week MA | $75.3 | 41% below |
| 200 week MA | $81.7 | 46% below |
SNDK has stronger trend alignment. DOX is above 0 of 5 weekly averages versus SNDK above 0 of 3.
SNDK Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $1,317.5 | 29% below |
| 20 week MA | $1,465.4 | 36% below |
| 50 week MA | $1,119.6 | 16% below |
SNDK is in a downtrend: it's below all three of its weekly moving averages, and 16% below its 50-week average.
DOX Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $72.6 | $69.7 | -4.1% |
| 2021 | $69.7 | $74.3 | +6.7% |
| 2022 | $74.3 | $89.4 | +20% |
| 2023 | $89.4 | $87.9 | -1.6% |
| 2024 | $87.9 | $85.8 | -2.4% |
| 2025 | $85.8 | $81.7 | -4.7% |
| 2026 YTD | $81.7 | $44.1 | -46% |
DOX has finished three years in a row lower, and it's down 46% so far in 2026.
SNDK Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2025 | $50.4 | $250.1 | +396% |
| 2026 YTD | $250.1 | $937.5 | +275% |
SNDK has the edge over DOX on returns for 2026, with the stronger performance.